Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 12 of these applications claim priority to application PCT/US2013/043888, filed Jun 3, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,713,617 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 9,725,455 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 9,828,383 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 10,065,968 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 10,106,548 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 10,125,140 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 10,266,540 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 10,294,231 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 10,294,232 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 10,752,634 | Crystalline Forms of a Brutons Tyrosine Kinase Inhibitor In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| 6 more patents in this group · Pro | ||||||
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16.
12 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.